URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

$16.42  -0.36 (-2.15%)
As of 06/18/2021 15:59:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/04/2017
Outstanding shares:  22,298,723
Average volume:  121,386
Market cap:   $374,172,572
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    M96088105
ISIN:        IL0011407140
Sedol:      BZ7PJQ1
Valuation   (See tab for details)
PE ratio:   -3.15
PB ratio:   4.79
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy